病例报告:用PD-1抑制剂和化疗治疗的恩病
Xiaohui Xie1, Qinyang Chen2, Jian Zhang1
1Department of Oncology, Chendu Second People's Hospital, Chengdu, China.
Frontiers in oncology
|October 13, 2025
概括
提斯莱利祖马布与capecitabine化疗相结合,有效地治疗了51岁男性的围博恩病. 这种治疗导致了显著的瘤减少和改善生活质量.
科学领域:
- 在瘤学瘤学.
- 皮肤病学 皮肤病学
- 免疫治疗是一种免疫疗法.
背景情况:
- 周围的恩病是一种罕见的皮肤内状状细胞癌.
- 晚期或耐火病例的治疗选择可能是有限的.
- 蒂斯莱利祖马布是一种针对PD-1的免疫检查点抑制剂.
研究的目的:
- 为了评估tislelizumab与capecitabine化疗相结合的疗效.
- 评估对患有围布温病的患者瘤负担和生活质量的影响.
主要方法:
- 一个单一的病例研究,涉及51岁的男性患者.
- 治疗方案包括tislelizumab和capecitabine化疗.
- 监测瘤反应和生活质量.
主要成果:
- 观察到周围门瘤大小的显著减少.
- 患者报告生活质量有所改善.
- 组合疗法被很好地容忍.
结论:
- 蒂斯莱利祖马布和capecitabine化学疗法在围博恩病中显示出有前途的疗效.
- 这种组合提供了一种潜在的治疗策略,可以改善患者的治疗结果.
- 需要在更大的队列中进行进一步的调查.
相关概念视频
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Chronic Bowel Disorders: Introduction
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...


